Infection and anti-tumor necrosis factor-alpha therapy.

Listeria monocytogenes sepsis in patients treated with anti-tumor necrosis factor-alpha. Isr Med Assoc J (2003) 0.80

Lung Infections in Systemic Rheumatic Disease: Focus on Opportunistic Infections. Int J Mol Sci (2017) 0.75

The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med (2013) 1.56

Systemic thromboembolism in inflammatory bowel disease: mechanisms and clinical applications. Ann N Y Acad Sci (2005) 1.39

Neuropsychiatric syndromes in systemic lupus erythematosus: a meta-analysis. Semin Arthritis Rheum (2010) 1.31

Novel biomarkers in autoimmune diseases: prolactin, ferritin, vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci (2007) 1.26

Biologic therapy for autoimmune diseases: an update. BMC Med (2013) 1.23

Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci (2007) 1.15

Drug-induced lupus: an update. Autoimmun Rev (2010) 1.13

An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology (2010) 1.08

Neuropsychiatric lupus: a mosaic of clinical presentations. BMC Med (2015) 1.00

Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients. Clin Rev Allergy Immunol (2012) 0.94

Autoantibodies in nonautoimmune individuals during infections. Ann N Y Acad Sci (2007) 0.93

The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases--2008. Isr Med Assoc J (2008) 0.92

Statins and autoimmunity. Immunol Res (2013) 0.91

The mosaic of autoimmunity: genetic factors involved in autoimmune diseases--2008. Isr Med Assoc J (2008) 0.90

The sense of smell in systemic lupus erythematosus. Arthritis Rheum (2009) 0.89

The neuroendocrine-immune interactions in systemic lupus erythematosus: a basis for understanding disease pathogenesis and complexity. Rheum Dis Clin North Am (2005) 0.89

B-cell directed therapies in antiphospholipid antibody syndrome--new directions based on murine and human data. Autoimmun Rev (2012) 0.85

Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev (2007) 0.84

The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. Int Immunol (2007) 0.84

Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases. Curr Pharm Des (2011) 0.83

Vaccines and autoimmune diseases of the adult. Discov Med (2010) 0.83

Autoantibody screen in inflammatory myopathies high prevalence of antibodies to gliadin. Ann N Y Acad Sci (2009) 0.82

Low dose intravenous immunoglobulin in systemic lupus erythematosus: analysis of 62 cases. Isr Med Assoc J (2008) 0.81

The mosaic of autoimmunity: prediction, autoantibodies, and therapy in autoimmune diseases--2008. Isr Med Assoc J (2008) 0.81

Ferritin and prolactin levels in multiple sclerosis. Isr Med Assoc J (2011) 0.81

Spontaneous rupture of the spleen detected on CT as the initial manifestation of infectious mononucleosis. Emerg Radiol (2003) 0.79

A long-term follow-up after cardiac transplantation in a lupus patient: case report and review of the literature. Ann N Y Acad Sci (2007) 0.79

Pathogenic role and clinical relevance of antineutrophil cytoplasmic antibodies in vasculitides. Curr Rheumatol Rep (2006) 0.79

Hemophagocytic syndrome with hyperferritinemia: a stormy immunological response. Isr Med Assoc J (2013) 0.79

Diffuse alveolar hemorrhage in autoimmune diseases. Isr Med Assoc J (2002) 0.79

[Infections in diabetic patients--a two-year experience from the Diabetic Foot Unit at Wolfson Medical Center]. Harefuah (2008) 0.78

Intravenous immunoglobulin and autoimmunity. Isr Med Assoc J (2010) 0.78

Intraocular inflammation in autoimmune diseases. Semin Arthritis Rheum (2004) 0.77

Points of interest from the 6th Autoimmunity Congress 9-13 September 2008, Porto, Portugal. Isr Med Assoc J (2009) 0.76

The 6th Autoimmunity Congress: meeting highlights. 6th International Congress on Autoimmunity, 9-13 September 2008, Porto, Portugal. Immunotherapy (2009) 0.75

Apoptosis and autoimmunity. Isr Med Assoc J (2002) 0.75

The beneficial effects of intravenous immunoglobulin for antineutrophil cytoplasmic antibody-positive vasculitis. Isr Med Assoc J (2012) 0.75

Gender influences SLE-immune cells, genetics, experimental models and lupus patients. Clin Exp Rheumatol (2010) 0.75

Destructive arthritis in a patient with Haim-munk syndrome. J Rheumatol (2004) 0.75

[Long-term therapy with endothelin-1 antagonist for pulmonary hypertension secondary to systemic sclerosis]. Harefuah (2008) 0.75

A patient with fever and pulmonary infiltrates. Isr Med Assoc J (2002) 0.75

Hypogammaglobulinemia 31 years after the diagnosis of systemic lupus erythematosus. Isr Med Assoc J (2004) 0.75

[Apoptosis in systemic lupus erythematosus]. Harefuah (2003) 0.75

What to do when the Diagnosis of Giant Cell Arteritis and Takayasu's Arteritis Overlap. Isr Med Assoc J (2015) 0.75

[Mycophenolate mofetil as a novel treatment for lupus nephritis]. Harefuah (2011) 0.75

Recurrent and bilateral deep vein thrombosis in a Crohn's patient. Isr Med Assoc J (2005) 0.75

Digital Ulcers, Systemic Sclerosis Sine Scleroderma and Paraneoplastic Phenomena Responding to Bosentan Therapy. Isr Med Assoc J (2015) 0.75